Compare AFLAC Incorporated (AFL) vs JPMorgan Chase & Co (JPM) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AFLAC Incorporated vs JPMorgan Chase & Co — how do they compare? AFLAC Incorporated trades at $121.46 (market cap $61.84B), while JPMorgan Chase & Co trades at $334 (market cap $908.94B). The key difference: JPMorgan Chase & Co is far larger — about 14.7× AFLAC Incorporated's market cap, and AFLAC Incorporated pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| AFL | JPM | |
|---|---|---|
Market Cap | $61.84B | $908.94B |
Sector | Financials | Financials |
52-Week High | $121.49 | $339.22 |
52-Week Low | $98.09 | $282.78 |
Enterprise Value | $70.50B | — |
Dividend Yield | 2.01% | 1.77% |
Volume | — | 10,479,943 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aflac (AFL) trades at $121.49, up 0.5% with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with a 25.32% net income margin and 16.47% ROE, though recent Q1 2026 earnings missed expectations. Analyst consensus is mixed with 28% buy ratings and a $113.57 price target below current levels. Recent developments include strong dividend performance and upcoming Q2 2026 results announcement on August 6, 2026.
The outlook remains cautiously optimistic with solid profitability and dividend stability, but faces headwinds from recent earnings misses and premium valuation pressure. Key opportunities include continued growth in Japan and U.S. markets, while risks involve medical cost inflation and uneven revenue trends. The stock's current premium to analyst targets suggests limited near-term upside potential.
JPMorgan Chase (JPM) trades at $332.64, down 1.5% on the day, as investors await Q2 2026 earnings results. The stock maintains a bullish technical outlook with strong moving average support and shows solid fundamentals with $181.85B revenue and 31.61% net income margin for 2025. Recent earnings beats in Q1 2026 ($5.94 vs $5.47 expected) demonstrate operational strength, while analyst consensus remains positive with a $360.38 price target.
JPMorgan presents a compelling investment case with industry-leading 17.03% ROE and reasonable 16.24 P/E valuation. Near-term catalysts include upcoming earnings and dividend payment, though risks persist from geopolitical tensions, cybersecurity threats, and CEO Dimon's warnings about economic challenges. The stock offers stability with institutional support but faces headwinds from interest rate sensitivity and global economic uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AFLAC Incorporated
Aflac Inc offers supplemental health insurance and life insurance in the two largest insurance markets in the world, the U.S. and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accidents, disability, and long-term-care insurance. It markets its products through independent distributors, selling most of its policies directly to consumers at their places of work.
Read more on AFL →About JPMorgan Chase & Co
JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.
Read more on JPM →
